Treatments for alopecia areata: a network meta-analysis

Monica  Novoa-Candia; Guillermo Sanchez-Vanegas; Ingrid Arevalo-rodriguez; Sergio Vano-Galvan; Mayra Rodriguez; Lucia Giraldo; David Saceda-Corralo; Aurelio Tobias Garces; Jacqueline Tomlinson; Daniel Ortega-Quijano; Javier Zamora

doi:10.1002/14651858.CD013719

^*Corresponding author for this work

Metabolism and Systems Science

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the comparative effectiveness and safety of interventions used in the management of alopecia areata (AA), including patchy alopecia (PA), alopecia totalis (AT) and alopecia universalis (AU). To establish rankings of the available treatments for AA, based on their effectiveness and safety (primary outcomes), through a network meta-analysis.

Original language	English
Article number	CD013719
Number of pages	20
Journal	Cochrane Database of Systematic Reviews
Volume	2020
Issue number	9
DOIs	https://doi.org/10.1002/14651858.CD013719
Publication status	Published - 10 Sept 2020

Bibliographical note

Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD013719

Cite this

@article{918a0a50026c4c4e9a5f2d7c6c937e16,

title = "Treatments for alopecia areata: a network meta-analysis",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the comparative effectiveness and safety of interventions used in the management of alopecia areata (AA), including patchy alopecia (PA), alopecia totalis (AT) and alopecia universalis (AU). To establish rankings of the available treatments for AA, based on their effectiveness and safety (primary outcomes), through a network meta-analysis.",

author = "Monica Novoa-Candia and Guillermo Sanchez-Vanegas and Ingrid Arevalo-rodriguez and Sergio Vano-Galvan and Mayra Rodriguez and Lucia Giraldo and David Saceda-Corralo and \{Tobias Garces\}, Aurelio and Jacqueline Tomlinson and Daniel Ortega-Quijano and Javier Zamora",

note = "Publisher Copyright: Copyright {\textcopyright} 2020 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd.",

year = "2020",

month = sep,

day = "10",

doi = "10.1002/14651858.CD013719",

language = "English",

volume = "2020",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Cochrane Collaboration",

number = "9",

}

TY - JOUR

T1 - Treatments for alopecia areata

T2 - a network meta-analysis

AU - Novoa-Candia, Monica

AU - Sanchez-Vanegas, Guillermo

AU - Arevalo-rodriguez, Ingrid

AU - Vano-Galvan, Sergio

AU - Rodriguez, Mayra

AU - Giraldo, Lucia

AU - Saceda-Corralo, David

AU - Tobias Garces, Aurelio

AU - Tomlinson, Jacqueline

AU - Ortega-Quijano, Daniel

AU - Zamora, Javier

PY - 2020/9/10

Y1 - 2020/9/10

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the comparative effectiveness and safety of interventions used in the management of alopecia areata (AA), including patchy alopecia (PA), alopecia totalis (AT) and alopecia universalis (AU). To establish rankings of the available treatments for AA, based on their effectiveness and safety (primary outcomes), through a network meta-analysis.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the comparative effectiveness and safety of interventions used in the management of alopecia areata (AA), including patchy alopecia (PA), alopecia totalis (AT) and alopecia universalis (AU). To establish rankings of the available treatments for AA, based on their effectiveness and safety (primary outcomes), through a network meta-analysis.

UR - https://www.scopus.com/pages/publications/85090579731

U2 - 10.1002/14651858.CD013719

DO - 10.1002/14651858.CD013719

M3 - Article

SN - 1469-493X

VL - 2020

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD013719